Influenza News and Research

Latest Influenza News and Research

Researchers identify link between socioeconomic status and common disease symptoms

Researchers have identified the link between socioeconomic status and common symptoms of disease, prompting new questions about the causal connections between them.

26 Mar 2010

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.

26 Mar 2010

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

Novavax, Inc. announced today positive results from the entire 1,000 subject Stage A of its two-stage pivotal study evaluating the safety and immunogenicity of Novavax's unadjuvanted 2009 A/H1N1 virus-like particle pandemic influenza vaccine.

26 Mar 2010

IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay granted EUA from FDA

IMDx announced today that its IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay has been granted Emergency Use Authorization from the U.S. Food and Drug Administration.

26 Mar 2010

Clinical Reference Laboratory completes validation testing of DNA Genotek's Oragene-DNA saliva collection kits

Clinical Reference Laboratory today announced that it has completed validation testing of DNA Genotek's Oragene-DNA saliva collection kits and will adopt Oragene-DNA for use with its molecular diagnostic services.

25 Mar 2010

FDA approves Riverain Medical's Softview Enhanced Chest Imaging technology

Riverain Medical, a leading image enhancement and computer-aided detection company dedicated to providing physicians with tools to assist in image interpretation, announced today that the U.S. Food and Drug Administration (FDA) has cleared the SoftView Enhanced Chest Imaging technology.

25 Mar 2010

Swine flu closely related to 1918 Spanish flu pandemic

In research on the swine flu virus it has been seen that the virus may seem new, but it has old relatives. An influenza virus which was pandemic in 1918 is seen to be very closely related, structurally speaking, to the H1N1 swine flu vaccine. This virus has the dubious distinction of having claimed between 40 million to 100 million lives in the flu wave of 1918.

25 Mar 2010

New study investigates effects of influenza among pregnant women

This spring, pregnant women in Bergen and Oslo will be invited to take part in the Norwegian Influenza Study (NorFlu). The aim is to find out how influenza in pregnancy affects maternal health and childhood development. NorFlu will also study any implications of vaccination during pregnancy.

25 Mar 2010

FDA approves Custom Spine's anterior cervical interbody device

Custom Spine announced today that it has received FDA clearance to market PATHWAY ACIF, an anterior cervical interbody spacer. This cervical interbody device compliments the company's low-profile anterior cervical plate system, Regent ACP, which was released this past November.

25 Mar 2010

Life Technologies' real-time PCR instrument available for IVD use in Europe

Life Technologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical laboratories from 22 countries and European institutions that develop in vitro molecular diagnostic assays in oncology, genetic disease and infectious disease will now be able to leverage the instrument’s regulatory clearance to develop tests for clinical applications.

24 Mar 2010

Washington State mercury-limit suspension for swine flu vaccine ends

When it comes to some diseases prevention still is better than cure and swine flu is one such disease. The sheer global panic that gripped nations last year is hard to forget. The PanvaxH1N1 vaccine is specifically manufactured to target the influenza (A) H1N1 strain known more popularly as swine flu. Getting the flu shots may be crucial in prevention of spread of the highly contagious disease. Health officials say that the H1N1 strain of flu is still circulating but at low levels.

24 Mar 2010

First reported Australian swine flu case of 2010 – gearing up with protective measures

Swine flu a form of influenza, became a major health scare assuming pandemic proportions starting in Mexico early last year. There were 37,000 confirmed cases in Australia with 5,000 hospitalizations, 700 admissions in intensive care units and 191 deaths.

23 Mar 2010

Chest x-rays may help identify high-risk H1N1 patients

A new study published in the April issue of Radiology suggests that chest x-rays may play an important role in the diagnosis and treatment of H1N1 influenza by predicting which patients are likely to become sicker.

23 Mar 2010

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

A new understanding of a certain cell in the immune system may help guide scientists in creating better flu vaccines, report researchers from the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston.

23 Mar 2010

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Pevion Biotech, the Swiss vaccine company, today announced that PEV7, the first vaccine for chronic recurrent thrush - recurrent vulvovaginal candidiasis has entered Phase 1 clinical trial.

22 Mar 2010

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Theraclone Sciences, Inc., announced that Zenyaku Kogyo Co. Ltd., has exercised its option for an exclusive license in the Japan territory to Theraclone’s influenza monoclonal antibody program. The collaboration utilizes Theraclone’s I-STAR™ technology to discover broadly protective monoclonal antibodies for the treatment of pandemic influenza and severe seasonal influenza.

22 Mar 2010

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Vical Incorporated announced today that the U.S. Navy, through the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., has awarded Vical a contract to conduct a Phase 1 clinical trial of the company's Vaxfectin®-formulated DNA vaccine against A/H1N1 pandemic influenza (swine flu).

22 Mar 2010

Researchers develop new compound to inhibit HIV transmission

A compound that can inhibit the transfer of HIV from one cell to another has been developed by researchers at the Institut de Biologie Structurale Jean-Pierre Ebel.

22 Mar 2010

Swine flu risk to pregnant women uncovered in landmark study

A study to be published in the British Medical Journal (BMJ) today has found 11 percent of pregnant women admitted to intensive care units (ICU) with 2009 A/H1N1 (swine flu) died, with 12 percent of babies born to them dying from complications. None of the mothers had been immunised against seasonal flu.

22 Mar 2010

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Providing independent advice to Member States is a very important function of the World Health Organization (WHO). We take this work seriously and guard against the influence of any improper interests. The WHO influenza pandemic policies and response have not been improperly influenced by the pharmaceutical industry.

20 Mar 2010

Influenza News and Research

Latest Influenza News and Research

Researchers identify link between socioeconomic status and common disease symptoms

Positive data from Shire's Phase III trial of TKT-034 in Type 1 Gaucher disease patients who switched to VPRIV

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay granted EUA from FDA

Clinical Reference Laboratory completes validation testing of DNA Genotek's Oragene-DNA saliva collection kits

FDA approves Riverain Medical's Softview Enhanced Chest Imaging technology

Swine flu closely related to 1918 Spanish flu pandemic

New study investigates effects of influenza among pregnant women

FDA approves Custom Spine's anterior cervical interbody device

Life Technologies' real-time PCR instrument available for IVD use in Europe

Washington State mercury-limit suspension for swine flu vaccine ends

First reported Australian swine flu case of 2010 – gearing up with protective measures

Chest x-rays may help identify high-risk H1N1 patients

New understanding of cell in immune system may guide creation of effective flu vaccines: Study

Pevion Biotech commences Phase 1 clinical trial of PEV7 vaccine

Zenyaku Kogyo receives license to Theraclone Sciences' influenza monoclonal antibody program

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Researchers develop new compound to inhibit HIV transmission

Swine flu risk to pregnant women uncovered in landmark study

Influenza pandemic policies: WHO denies being improperly influenced by pharmaceutical industry

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Influenza News and Research

Latest Influenza News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in